IL4I1 and neoplasm: An important feature of cancer biology is the identification [28] of IL-4I1 (L-Phe oxidase) as a metabolic immune checkpoint that activates the AhR and promotes tumour progression by enhancing cancer cell motility and suppressing adaptive immunity.